Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 70S ribosome 30S subunit A-site, also known as the aminoacyl-tRNA binding site or decoding center, is a fundamental component of the bacterial translation apparatus (Schmeing & Ramakrishnan, 2009, Nature). It is primarily composed of highly conserved sequences within the 16S ribosomal RNA (rRNA), specifically helix 44, which facilitates the high-fidelity selection of aminoacyl-tRNAs based on mRNA codons (Vicens & Westhof, 2003, ChemBioChem). This site is the primary pharmacological target for several classes of broad-spectrum antibiotics used to treat bacterial infections. Aminoglycosides, such as gentamicin and amikacin, bind directly to the A-site, causing a conformational change that reduces the accuracy of the decoding process, leading to the synthesis of mistranslated, dysfunctional proteins (Magnet & Blanchard, 2005, Chem. Rev.). Tetracyclines also target this region by sterically hindering the binding of aminoacyl-tRNA to the A-site, thereby halting protein synthesis (Chopra & Roberts, 2001, Microbiol. Mol. Biol. Rev.). While these drugs are effective against a wide range of pathogens, their use is often limited by safety concerns such as nephrotoxicity and ototoxicity, which can occur due to structural similarities between bacterial and human mitochondrial ribosomes (Guthrie, 2008, Semin. Hear.).
Aminoglycosides bind to the 16S rRNA A-site to induce mRNA misreading and translocation inhibition (Magnet & Blanchard, 2005, Chem. Rev.); Tetracyclines sterically block the A-site to prevent aminoacyl-tRNA binding (Chopra & Roberts, 2001, Microbiol. Mol. Biol. Rev.).
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 70S ribosome 30S subunit A-site (30S A-site) (30S A-site).